{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:42:01Z","timestamp":1793403721101,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chromosome changes are one of the hallmarks of human malignancies. Chromosomal rearrangement is frequent in human cancers. One of the consequences of chromosomal rearrangement is gene fusions in the cancer genome. We have previously identified a panel of fusion genes in aggressive prostate cancers. In this study, we showed that 6 of these fusion genes are present in 7 different types of human malignancies with variable frequencies. Among them, the CCNH-C5orf30 and TRMT11-GRIK2 gene fusions were found in breast cancer, colon cancer, non-small cell lung cancer, esophageal adenocarcinoma, glioblastoma multiforme, ovarian cancer and liver cancer, with frequencies ranging from 12.9% to 85%. In contrast, four other gene fusions (mTOR-TP53BP1, TMEM135-CCDC67, KDM4-AC011523.2 and LRRC59-FLJ60017) are less frequent. Both TRMT11-GRIK2 and CCNH-C5orf30 are also frequently present in lymph node metastatic cancer samples from the breast, colon and ovary. Thus, detecting these fusion transcripts may have significant biological and clinical implications in cancer patient management.<\/jats:p>","DOI":"10.1038\/s41598-019-38550-6","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T11:04:33Z","timestamp":1548932673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Identification of recurrent fusion genes across multiple cancer types"],"prefix":"10.1038","volume":"9","author":[{"given":"Yan-Ping","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald L.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9922-6920","authenticated-orcid":false,"given":"George","family":"Michalopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7886-6187","authenticated-orcid":false,"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Pennathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Luketich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nalesnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,31]]},"reference":[{"key":"38550_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA: a cancer journal for clinicians 68, 7\u201330, https:\/\/doi.org\/10.3322\/caac.21442 (2018).","journal-title":"CA: a cancer journal for clinicians"},{"key":"38550_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"38550_CR3","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1200\/JCO.2004.05.158","volume":"22","author":"YP Yu","year":"2004","unstructured":"Yu, Y. P. et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 22, 2790\u20132799 (2004).","journal-title":"J Clin Oncol"},{"key":"38550_CR4","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/hep.21328","volume":"44","author":"JH Luo","year":"2006","unstructured":"Luo, J. H. et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology (Baltimore, Md 44, 1012\u20131024 (2006).","journal-title":"Hepatology (Baltimore, Md"},{"key":"38550_CR5","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1016\/j.ajpath.2012.03.008","volume":"180","author":"YP Yu","year":"2012","unstructured":"Yu, Y. P. et al. Genome abnormalities precede prostate cancer and predict clinical relapse. The American journal of pathology 180, 2240\u20132248 (2012).","journal-title":"The American journal of pathology"},{"key":"38550_CR6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1358\/dot.2002.38.10.704653","volume":"38","author":"JH Luo","year":"2002","unstructured":"Luo, J. H. Gene expression alterations in human prostate cancer. Drugs Today (Barc) 38, 713\u2013719 (2002).","journal-title":"Drugs Today (Barc)"},{"key":"38550_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399403006057","volume":"5","author":"JH Luo","year":"2003","unstructured":"Luo, J. H. & Yu, Y. P. Genetic factors underlying prostate cancer. Expert reviews in molecular medicine 5, 1\u201326 (2003).","journal-title":"Expert reviews in molecular medicine"},{"key":"38550_CR8","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.ajpath.2013.02.040","volume":"182","author":"JH Luo","year":"2013","unstructured":"Luo, J. H. et al. Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer. The American journal of pathology 182, 2028\u20132036 (2013).","journal-title":"The American journal of pathology"},{"key":"38550_CR9","doi-asserted-by":"publisher","first-page":"e0135982","DOI":"10.1371\/journal.pone.0135982","volume":"10","author":"YP Yu","year":"2015","unstructured":"Yu, Y. P. et al. Genomic Copy Number Variations in the Genomes of Leukocytes Predict Prostate Cancer Clinical Outcomes. PloS one 10, e0135982 (2015).","journal-title":"PloS one"},{"key":"38550_CR10","first-page":"1291","volume":"22","author":"YP Yu","year":"2007","unstructured":"Yu, Y. P. & Luo, J. H. Pathological factors evaluating prostate cancer. Histology and histopathology 22, 1291\u20131300 (2007).","journal-title":"Histology and histopathology"},{"key":"38550_CR11","doi-asserted-by":"crossref","unstructured":"Yu, Y. P. et al. Whole-Genome Methylation Sequencing Reveals Distinct Impact of Differential Methylations on Gene Transcription in Prostate Cancer. The American journal of pathology (2013).","DOI":"10.1016\/j.ajpath.2013.08.018"},{"key":"38550_CR12","doi-asserted-by":"publisher","first-page":"A22","DOI":"10.1080\/00325481.1961.11694500","volume":"30","author":"ES Benson","year":"1961","unstructured":"Benson, E. S. Leukemia and the Philadelphia chromosome. Postgrad Med 30, A22\u2013A28 (1961).","journal-title":"Postgrad Med"},{"key":"38550_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1128\/MCB.5.1.204","volume":"5","author":"RL Davis","year":"1985","unstructured":"Davis, R. L., Konopka, J. B. & Witte, O. N. Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties. Molecular and cellular biology 5, 204\u2013213 (1985).","journal-title":"Molecular and cellular biology"},{"key":"38550_CR14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/jvi.54.1.114-122.1985","volume":"54","author":"R Prywes","year":"1985","unstructured":"Prywes, R., Foulkes, J. G. & Baltimore, D. The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase. Journal of virology 54, 114\u2013122 (1985).","journal-title":"Journal of virology"},{"key":"38550_CR15","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.1117679","volume":"310","author":"SA Tomlins","year":"2005","unstructured":"Tomlins, S. A. et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science New York, N.Y 310, 644\u2013648 (2005).","journal-title":"Science New York, N.Y"},{"key":"38550_CR16","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1016\/j.ajpath.2014.06.025","volume":"184","author":"YP Yu","year":"2014","unstructured":"Yu, Y. P. et al. Novel fusion transcripts associate with progressive prostate cancer. The American journal of pathology 184, 2840\u20132849 (2014).","journal-title":"The American journal of pathology"},{"key":"38550_CR17","doi-asserted-by":"crossref","unstructured":"Luo, J. H. et al. Discovery and Classification of Fusion Transcripts in Prostate Cancer and Normal Prostate Tissue. The American journal of pathology (2015).","DOI":"10.1016\/j.ajpath.2015.03.008"},{"key":"38550_CR18","doi-asserted-by":"publisher","first-page":"12465","DOI":"10.1073\/pnas.0905931106","volume":"106","author":"Y Zong","year":"2009","unstructured":"Zong, Y. et al. ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells. Proceedings of the National Academy of Sciences of the United States of America 106, 12465\u201312470 (2009).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"38550_CR19","doi-asserted-by":"publisher","unstructured":"Chen, Z. H. et al. MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice. Gastroenterology, https:\/\/doi.org\/10.1053\/j.gastro.2016.12.036 (2017).","DOI":"10.1053\/j.gastro.2016.12.036"},{"key":"38550_CR20","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1038\/onc.2014.406","volume":"34","author":"K Yoshihara","year":"2015","unstructured":"Yoshihara, K. et al. The landscape and therapeutic relevance of cancer-associated transcript fusions. Oncogene 34, 4845\u20134854, https:\/\/doi.org\/10.1038\/onc.2014.406 (2015).","journal-title":"Oncogene"},{"key":"38550_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nbt.3080","volume":"33","author":"C Klijn","year":"2015","unstructured":"Klijn, C. et al. A comprehensive transcriptional portrait of human cancer cell lines. Nature biotechnology 33, 306\u2013312, https:\/\/doi.org\/10.1038\/nbt.3080 (2015).","journal-title":"Nature biotechnology"},{"key":"38550_CR22","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.celrep.2013.08.022","volume":"4","author":"S Li","year":"2013","unstructured":"Li, S. et al. Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. Cell reports 4, 1116\u20131130, https:\/\/doi.org\/10.1016\/j.celrep.2013.08.022 (2013).","journal-title":"Cell reports"},{"key":"38550_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1158\/2159-8290.CD-17-0535","volume":"8","author":"KJ Matissek","year":"2018","unstructured":"Matissek, K. J. et al. Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer. Cancer discovery 8, 336\u2013353, https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0535 (2018).","journal-title":"Cancer discovery"},{"key":"38550_CR24","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.celrep.2018.07.009","volume":"24","author":"JT Lei","year":"2018","unstructured":"Lei, J. T. et al. Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-PositiveBreast Cancer. Cell reports 24, 1434\u20131444e1437, https:\/\/doi.org\/10.1016\/j.celrep.2018.07.009 (2018).","journal-title":"Cell reports"},{"key":"38550_CR25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/gcc.22279","volume":"54","author":"J Kim","year":"2015","unstructured":"Kim, J. et al. Recurrent fusion transcripts detected by whole-transcriptome sequencing of 120 primary breast cancer samples. Genes, chromosomes & cancer 54, 681\u2013691, https:\/\/doi.org\/10.1002\/gcc.22279 (2015).","journal-title":"Genes, chromosomes & cancer"},{"key":"38550_CR26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature05945","volume":"448","author":"M Soda","year":"2007","unstructured":"Soda, M. et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448, 561\u2013566, https:\/\/doi.org\/10.1038\/nature05945 (2007).","journal-title":"Nature"},{"key":"38550_CR27","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nm.2658","volume":"18","author":"K Takeuchi","year":"2012","unstructured":"Takeuchi, K. et al. RET, ROS1 and ALK fusions in lung cancer. Nature medicine 18, 378\u2013381, https:\/\/doi.org\/10.1038\/nm.2658 (2012).","journal-title":"Nature medicine"},{"key":"38550_CR28","doi-asserted-by":"publisher","first-page":"e0200215","DOI":"10.1371\/journal.pone.0200215","volume":"13","author":"J Davidsen","year":"2018","unstructured":"Davidsen, J. et al. The VTI1A-TCF4 colon cancer fusion protein is a dominant negative regulator of Wnt signaling and is transcriptionally regulated by intestinal homeodomain factor CDX2. PloS one 13, e0200215, https:\/\/doi.org\/10.1371\/journal.pone.0200215 (2018).","journal-title":"PloS one"},{"key":"38550_CR29","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/cncr.30510","volume":"123","author":"Z Sun","year":"2017","unstructured":"Sun, Z. et al. The novel fusion transcript NR5A2-KLHL29FT is generated by an insertion at the KLHL29 locus. Cancer 123, 1507\u20131515, https:\/\/doi.org\/10.1002\/cncr.30510 (2017).","journal-title":"Cancer"},{"key":"38550_CR30","doi-asserted-by":"publisher","first-page":"e91264","DOI":"10.1371\/journal.pone.0091264","volume":"9","author":"T Nome","year":"2014","unstructured":"Nome, T. et al. High frequency of fusion transcripts involving TCF7L2 in colorectal cancer: novel fusion partner and splice variants. PloS one 9, e91264, https:\/\/doi.org\/10.1371\/journal.pone.0091264 (2014).","journal-title":"PloS one"},{"key":"38550_CR31","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1126\/science.1220834","volume":"337","author":"D Singh","year":"2012","unstructured":"Singh, D. et al. Transforming fusions of FGFR and TACC genes in human glioblastoma. Science New York, N.Y 337, 1231\u20131235, https:\/\/doi.org\/10.1126\/science.1220834 (2012).","journal-title":"Science New York, N.Y"},{"key":"38550_CR32","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1101\/gr.165126.113","volume":"24","author":"ZS Bao","year":"2014","unstructured":"Bao, Z. S. et al. RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas. Genome research 24, 1765\u20131773, https:\/\/doi.org\/10.1101\/gr.165126.113 (2014).","journal-title":"Genome research"},{"key":"38550_CR33","doi-asserted-by":"publisher","first-page":"13076","DOI":"10.1073\/pnas.1716483114","volume":"114","author":"ER Kastenhuber","year":"2017","unstructured":"Kastenhuber, E. R. et al. DNAJB1-PRKACA fusion kinase interacts with beta-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America 114, 13076\u201313084, https:\/\/doi.org\/10.1073\/pnas.1716483114 (2017).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"38550_CR34","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.1249484","volume":"343","author":"JN Honeyman","year":"2014","unstructured":"Honeyman, J. N. et al. Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. Science (New York, N.Y 343, 1010\u20131014, https:\/\/doi.org\/10.1126\/science.1249484 (2014).","journal-title":"Science (New York, N.Y"},{"key":"38550_CR35","doi-asserted-by":"publisher","first-page":"40693","DOI":"10.18632\/oncotarget.17244","volume":"8","author":"Y Huang","year":"2017","unstructured":"Huang, Y. et al. Transcriptome profiling identifies a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma. Oncotarget 8, 40693\u201340704, https:\/\/doi.org\/10.18632\/oncotarget.17244 (2017).","journal-title":"Oncotarget"},{"key":"38550_CR36","doi-asserted-by":"publisher","first-page":"46891","DOI":"10.18632\/oncotarget.16781","volume":"8","author":"MA Earp","year":"2017","unstructured":"Earp, M. A. et al. Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes. Oncotarget 8, 46891\u201346899, https:\/\/doi.org\/10.18632\/oncotarget.16781 (2017).","journal-title":"Oncotarget"},{"key":"38550_CR37","doi-asserted-by":"publisher","first-page":"E1272","DOI":"10.1073\/pnas.1501735112","volume":"112","author":"K Kannan","year":"2015","unstructured":"Kannan, K. et al. Recurrent BCAM-AKT2 fusion gene leads to a constitutively activated AKT2 fusion kinase in high-grade serous ovarian carcinoma. Proceedings of the National Academy of Sciences of the United States of America 112, E1272\u20131277, https:\/\/doi.org\/10.1073\/pnas.1501735112 (2015).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"38550_CR38","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1002\/ijc.24958","volume":"126","author":"CS Wu","year":"2010","unstructured":"Wu, C. S. et al. Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer. International journal of cancer 126, 2542\u20132552, https:\/\/doi.org\/10.1002\/ijc.24958 (2010).","journal-title":"International journal of cancer"},{"key":"38550_CR39","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1126\/science.1076182","volume":"298","author":"B Wang","year":"2002","unstructured":"Wang, B., Matsuoka, S., Carpenter, P. B. & Elledge, S. J. 53BP1, a mediator of the DNA damage checkpoint. Science (New York, N.Y 298, 1435\u20131438, https:\/\/doi.org\/10.1126\/science.1076182 (2002).","journal-title":"Science (New York, N.Y"},{"key":"38550_CR40","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1093\/carcin\/bgs178","volume":"33","author":"SJ Park","year":"2012","unstructured":"Park, S. J. et al. Epigenetic alteration of CCDC67 and its tumor suppressor function in gastric cancer. Carcinogenesis 33, 1494\u20131501, https:\/\/doi.org\/10.1093\/carcin\/bgs178 (2012).","journal-title":"Carcinogenesis"},{"key":"38550_CR41","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1083\/jcb.151.7.1381","volume":"151","author":"LB Schultz","year":"2000","unstructured":"Schultz, L. B., Chehab, N. H., Malikzay, A. & Halazonetis, T. D. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. The Journal of cell biology 151, 1381\u20131390 (2000).","journal-title":"The Journal of cell biology"},{"key":"38550_CR42","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1128\/MCB.23.7.2556-2563.2003","volume":"23","author":"IM Ward","year":"2003","unstructured":"Ward, I. M., Minn, K., van Deursen, J. & Chen, J. p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice. Molecular and cellular biology 23, 2556\u20132563 (2003).","journal-title":"Molecular and cellular biology"},{"key":"38550_CR43","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1093\/nar\/gkw1271","volume":"45","author":"G Bourgeois","year":"2017","unstructured":"Bourgeois, G., Marcoux, J., Saliou, J. M., Cianferani, S. & Graille, M. Activation mode of the eukaryotic m2G10 tRNA methyltransferase Trm11 by its partner protein Trm112. Nucleic acids research 45, 1971\u20131982, https:\/\/doi.org\/10.1093\/nar\/gkw1271 (2017).","journal-title":"Nucleic acids research"},{"key":"38550_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev-genet-110711-155641","volume":"46","author":"B El Yacoubi","year":"2012","unstructured":"El Yacoubi, B., Bailly, M. & de Crecy-Lagard, V. Biosynthesis and function of posttranscriptional modifications of transfer RNAs. Annu Rev Genet 46, 69\u201395, https:\/\/doi.org\/10.1146\/annurev-genet-110711-155641 (2012).","journal-title":"Annu Rev Genet"},{"key":"38550_CR45","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1006\/geno.1994.1198","volume":"20","author":"W Paschen","year":"1994","unstructured":"Paschen, W., Blackstone, C. D., Huganir, R. L. & Ross, C. A. Human GluR6 kainate receptor (GRIK2): molecular cloning, expression, polymorphism, and chromosomal assignment. Genomics 20, 435\u2013440, https:\/\/doi.org\/10.1006\/geno.1994.1198 (1994).","journal-title":"Genomics"},{"key":"38550_CR46","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1038\/sj.onc.1205690","volume":"21","author":"E Schneider","year":"2002","unstructured":"Schneider, E., Kartarius, S., Schuster, N. & Montenarh, M. The cyclin H\/cdk7\/Mat1 kinase activity is regulated by CK2 phosphorylation of cyclin H. Oncogene 21, 5031\u20135037, https:\/\/doi.org\/10.1038\/sj.onc.1205690 (2002).","journal-title":"Oncogene"},{"key":"38550_CR47","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/emboj\/16.5.958","volume":"16","author":"G Andersen","year":"1997","unstructured":"Andersen, G. et al. The structure of cyclin H: common mode of kinase activation and specific features. The EMBO journal 16, 958\u2013967, https:\/\/doi.org\/10.1093\/emboj\/16.5.958 (1997).","journal-title":"The EMBO journal"},{"key":"38550_CR48","doi-asserted-by":"publisher","first-page":"11618","DOI":"10.1073\/pnas.1501947112","volume":"112","author":"M Muthana","year":"2015","unstructured":"Muthana, M. et al. C5orf30 is a negative regulator of tissue damage in rheumatoid arthritis. Proceedings of the National Academy of Sciences of the United States of America 112, 11618\u201311623, https:\/\/doi.org\/10.1073\/pnas.1501947112 (2015).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"38550_CR49","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrrheum.2015.139","volume":"11","author":"S Onuora","year":"2015","unstructured":"Onuora, S. Rheumatoid arthritis: C5orf30 regulates severity of tissue destruction in RA. Nat Rev Rheumatol 11, 622, https:\/\/doi.org\/10.1038\/nrrheum.2015.139 (2015).","journal-title":"Nat Rev Rheumatol"},{"key":"38550_CR50","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nbt.3843","volume":"35","author":"ZH Chen","year":"2017","unstructured":"Chen, Z. H. et al. Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene. Nature biotechnology 35, 543\u2013550, https:\/\/doi.org\/10.1038\/nbt.3843 (2017).","journal-title":"Nature biotechnology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-38550-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-38550-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-38550-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T05:23:03Z","timestamp":1671254583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-38550-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["38550"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-38550-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,31]]},"assertion":[{"value":"12 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1074"}}